Clinical trial
Immunogenicity and Safety of a Rabies Vaccine (Serum-free Vero Cell), Freeze-dried in Comparison With Verorab®, in a Simulated Post-exposure Prophylaxis Regimen in Healthy Populations Aged ≥1 Years: A Randomized, Double-Blind, Active-controlled Phase Ⅲ Clinical Trial
NCT07055893 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety of a Rabies Vaccine (Serum-free Vero Cell), Freeze-dried in Comparison With Verorab®, in a Simulated Post-exposure Prophylaxis Regimen in Healthy Populations Aged ≥1 Years: A Randomized, Double-Blind, Active-controlled Phase Ⅲ Clinical Trial
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- January 30, 2027
- Enrollment
- 390 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rabies (healthy volunteers)